Keyword: CVR


Pfizer-AstraZeneca Deal Still Occupies Analysts’ Fantasy

16.06.2014 - The world's biggest would-be drugs merger hit a wall last month but speculation about smart ways that Pfizer could yet seal a deal with AstraZeneca remains intense. Even as talks...


Sanofi Says CVR Interesting, No Comment on Genzyme

02.12.2010 - Sanofi-Aventis's CFO said a deal structure known as a contingent value right was interesting "in principle" but he declined to say if it was being discussed with bid target Genzyme...